Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Impact of Bone Marrow Fibrosis in MDS Patients Treated with Azacitidine

Danielle Hammond, MD, Mina Jamali, MD MSc, Richard A. Wells, MD DPhil, Liying Zhang, PhD, Alex Mamedov, Martha Lenis, Rena Buckstein, MD

Blood (2016) 128 (22): 4339.

https://doi.org/10.1182/blood.V128.22.4339.4339

Published: 2016

Journal Articles

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

Ambica Parmar, MD, Heather A Leitch, MD PhD, Richard A. Wells, MD DPhil, Thomas J. Nevill, MD FRCPC, Nancy Y Zhu, MDFRCPC, Karen W.L. Yee, MD, Brian Leber, MD, Mitchell Sabloff, MDM, Eve St-Hilaire, MD, Rajat Kumar, MD, Michelle Geddes, MD FRCPC, John Storring, MD, Andrea Kew, MD, April Shamy, MDM, Mohamed Elemary, MD MSc,PhD, Martha Lenis, Alex Mamedov, Rena Buckstein, MD FRCPC

Blood (2015) 126 (23): 1701.

https://doi.org/10.1182/blood.V126.23.1701.1701

Published: 2015

Journal Articles

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Rena Buckstein, MD, Richard A. Wells, MD DPhil, Nancy Zhu, MD, Thomas J. Nevill, MD, Heather A Leitch, MD PhD, Karen W.L. Yee, MD, Brian Leber, MD, Mitchell Sabloff, MDM, Rajat Kumar, MD, Michelle Geddes, MD, April Shamy, MDM, Max Levitt, Martha Lenis, Alex Mamedov, Liying Zhang, PhD, Shabbir MH Alibhai, MD

Blood (2014) 124 (21): 165.

https://doi.org/10.1182/blood.V124.21.165.165

Published: 2014

Journal Articles

Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

Aliza Saskin, Yulia Lin, MD, Richard A. Wells, MD DPhil, Martha Lenis, Alex Mamedov, Jeannie Callum, MD, Rena Buckstein, MD FRCPC

Blood (2014) 124 (21): 4297.

https://doi.org/10.1182/blood.V124.21.4297.4297

Published: 2014

Journal Articles

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria

Jennifer Jayakar, Richard A. Wells, MD, DPhil, Dina Khalaf, MD, Alex Mamedov, Adam Lam, Martha Lenis, Rena Buckstein, MD

Blood (2012) 120 (21): 1721.

https://doi.org/10.1182/blood.V120.21.1721.1721

Published: 2012

Journal Articles

The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients

Rena Buckstein, MD, Shabbir M.H. Alibhai, MD, Dina Khalaf, MD, Adam Lam, Alex Mamedov, Lisa Chodirker, MD, Liying Zhang, PhD, Martha Lenis, Matthew Cheung, MD, Jeannie Callum, MD, Janey Hsiao, MD, Yulia Lin, MD, Kenneth Rockwood, MD, Richard A. Wells, MD, DPhil

Blood (2012) 120 (21): 699.

https://doi.org/10.1182/blood.V120.21.699.699

Published: 2012

Journal Articles

The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment

Eric Tseng, MD, FRCPC, Richard A. Wells, MD, DPhil, Shabbir MH Alibhai, MD, MSc, FRCP(C), Adam Lam, Alex Mamedov, Lisa Chodirker, MD, Liying Zhang, PhD, Dina Khalaf, MD, Anca Prica, MD, Martha Lenis, Rena Buckstein, MD

Blood (2012) 120 (21): 4938.

https://doi.org/10.1182/blood.V120.21.4938.4938

Published: 2012

Journal Articles

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Sarah A. Ingber, MD, Kim Thompson, Adam Lam, Alex Mamedov, Liying Zhang, PhD, Alibhai Shabbir, MD, David Good, MD, Alden Chesney, MD, Marciano D. Reis, MD, Matthew Cheung, MD, Vicky Harris, RN, Richard A. Wells, MD, DPhil, Rena Buckstein, MD

Blood (2010) 116 (21): 2571.

https://doi.org/10.1182/blood.V116.21.2571.2571

Published: 2010

Journal Articles

Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study.

Rena Buckstein, MD, Shabbir Alibhai, MD, Adam Lam, Liying Zhang, Alex Mamedov, Matthew C Cheung, MD, Jeannie Callum, MD, Eugenia Piliotis, MD, Janey Tsiao, MD, Yulia Lin, MD, Richard A. Wells, MD, DPhil

Blood (2009) 114 (22): 2500.

https://doi.org/10.1182/blood.V114.22.2500.2500

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Impact of Bone Marrow Fibrosis in MDS Patients Treated with Azacitidine

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria

The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients

The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only